Today, the first-ever U.S.-based injection of a human patient with an “investigational” vaccine went forward. The patient, shown in the tweet below, represents “phase 1” of the vaccine, which was produced by Moderna.
Though this is a promising step, public health officials still say it will take a year to 18 months to fully test and validate any vaccine.
The first-ever injection of an investigational vaccine for the deadly coronavirus happened in Kaiser Permanente Washington Health Research Institute (KPWHRI), reports the institute’s blog.
As of writing, no other U.S.-based trial had been launched in real human patients of any vaccine for this radical virus, which causes COVID-19. The KPWHRI trial initially recruited participants on March 3.